Revvity | PKI - PE Price to Earnings


Revvity reported 36.47 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
Agilent 20.53 4.51 Mar/2026
Align Technology 21.8 0.98 Jun/2026
Bio Techne 38.75 81.27 Mar/2026
Bio-Rad Laboratories 10.01 15.27 Mar/2026
Bruker 46.54 9.74 Jun/2026
Celltrion 58.97 8.86 Mar/2026
Charles River Laboratories 58.27 29 Jun/2026
Cspc Pharmaceutical 23.62 0.78 Mar/2026
Danaher 32.68 3.4 Jun/2026
Dentsply International 20.31 9.68 Mar/2026
Deva Holding AS 6.55 2.01 Sep/2023
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 58.35 1.4 Jun/2026
Edwards Lifesciences 30.77 3.9 Jun/2026
Illumina 48.98 16.53 Jun/2026
Intuitive Surgical 44.59 11.23 Jun/2026
IQVIA Holdings 21.45 2.08 Jun/2026
Kangmei Pharma 1.11K 2.04K Mar/2026
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Laboratory Of America 20.47 5.04 Jun/2026
Malin Corporation 11.81 0.72 Jun/2023
Mettler Toledo International 27.29 0.04 Jun/2026
Neuren Pharmaceuticals 72.14 59.86 Dec/2025
OraSure Technologies 24.42 12.6 Sep/2024
Organigram Holdings 12.01 222.99 Mar/2026
Ovoca Bio 1.83 3.29 Jun/2024
Pharma Mar 16.35 2.78 Jun/2026
Qiagen NV 19.48 1.06 Mar/2026
Quest Diagnostics 21.23 1.17 Jun/2026
Quidel 2.03 70.39 Dec/2025
Repligen 105.09 4.39 Jun/2026
Revvity 36.47 5.68 Jun/2026
Sartorius 52.99 9.56 Jun/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Thermo Fisher Scientific 26.4 1.31 Jun/2026
Tilray 11.56 80.19 Sep/2025
Waters 66.69 36.94 Jun/2026
Zealand Pharma A/S 3.27 1.86 Mar/2026
Zz Pientze Pharmaceu 47.68 1.35 Mar/2026